We are delighted to share the news of the recent success of Aqilion, who secured an exclusive license and strategic research collaboration with Merck. The deal is worth up to EUR 950 million for their pre-clinical TAK1 inhibitor program....
Read MoreFive times during the last six years, Red Glead Discovery AB has been recognized as a Gasell company by Scandinavia’s largest business paper, Dagens Industri. The award is given annually to fast-growing and profitable Swedish companies with sound finances...
Read MoreEvaluation of gold-based compounds as Plasmodium falciparum aquaglyceroporin inhibitors An extensive cross-disciplinary study involving computational chemistry, synthesis and in vitro testing returned promising insights on the application of metal complexes for the treatment of drug-resistant malaria. During the investigation,...
Read MoreLund, Sweden August 30th, 2022 Red Glead Discovery has set emissions reduction targets through the Science Based Targets initiative (SBTi), with levels required to meet the goals of the Paris Agreement. Red Glead Discovery has now...
Read MoreCopenhagen, Denmark and Lund, Sweden February 22nd, 2022 In this unique strategic partnership, Desupervised and Red Glead Discovery join forces to create robust AI-based solutions enabling companies to reduce cost and time in small molecule drug research and...
Read MoreOur co-worker Johan Wennerberg has been appointed Adjunct Professor in Organic Chemistry with a focus on green process development at The Faculty of Engineering, LTH, Lund University. In his new role, Johan will contribute to more interactions between academia...
Read MoreRed Glead Discovery AB have appointed Ann Helen Forsling as CFO to strengthen the capacity of its executive management team. Forsling have previously worked at BLS industries as a CFO for the last three years and prior to that...
Read MoreRed Glead Discovery has been recognized as a Gazelle 2021 for the fourth time in five years! Less than 1% of Swedish companies qualify for this “fast-growth-award”. Another great recognition for the fantastic work performed by our engaged co-workers.
Read MoreInterview with Johan Evenäs, CEO of Red Glead Discovery, in Swedens leading Life Science magazine: https://www.lifesciencesweden.se/article/view/810694/red_gleads_vd_vi_var_inga_typiska_entreprenorer_nu_vill_de_vaxa?token=7p8svttcr7zmh6ri8pe78ct4r5hlc5ij
Read More10-year celebrating Red Glead Discovery expects 30% higher turnover for 2021 reflecting increasing customer demand for integrated drug discovery services. Privately held Life Science consultancy company Red Glead Discovery celebrates its 10-year anniversary this month. This important milestone could...
Read More